Protalix BioTherapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Bashan Dror | PRESIDENT AND CEO | Purchase | 56,000 | $1.81 | $101,360 | 188,516 | Dec 19, 2025 |
| Bar-Shalev Amos | — | Sale | 168 | $1.87 | $314 | — | Nov 18, 2025 |
| Forster Eliot | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Elze Christian | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Melincoff Gwen A | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Boudes Pol F | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Schwartz Aharon | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Ben Zvi Shmuel | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Bar-Shalev Amos | — | Award / Grant | 7,500 | — | — | 7,500 | Sep 3, 2025 |
| Naos Yaron | Sr. VP, Operations | Award / Grant | 25,000 | — | — | 225,817 | Sep 3, 2025 |
| Bashan Dror | PRESIDENT AND CEO | Award / Grant | 195,000 | — | — | 2,344,418 | Sep 3, 2025 |
| Schwartz Aharon | — | Purchase | 129,000 | $1.60 | $206,400 | 303,000 | Jun 10, 2025 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 90,909 | — | — | 660,909 | Sep 23, 2024 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 99,010 | — | — | 669,010 | Sep 23, 2024 |
| Bashan Dror | PRESIDENT AND CEO | Award / Grant | 263,960 | — | — | 2,149,418 | Apr 1, 2024 |
| Bashan Dror | PRESIDENT AND CEO | Purchase | 48,387 | $1.40 | $67,742 | 116,387 | Oct 19, 2023 |
| Bashan Dror | President and CEO | Award / Grant | 800,000 | — | — | 1,885,458 | Aug 15, 2023 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 201,903 | — | — | 570,000 | Aug 15, 2023 |
| Hayon Yael | VP, Research & Development | Award / Grant | 35,115 | — | — | 35,115 | Aug 15, 2023 |
| Naos Yaron | Sr. VP, Operations | Award / Grant | 187,344 | — | — | 200,817 | Aug 15, 2023 |
| Schwartz Aharon | — | Purchase | 110,000 | $1.42 | $156,200 | 174,000 | Jan 3, 2023 |
| Bashan Dror | President and CEO | Purchase | 68,000 | $1.50 | $102,000 | 68,000 | Apr 11, 2022 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 121,951 | — | — | 368,097 | Feb 25, 2022 |
| Bashan Dror | President and CEO | Award / Grant | 637,531 | — | — | 1,085,458 | Feb 25, 2022 |
| Oren Dan | — | Sale | 857,506 | $2.25 | $1,929,389 | 3,637,314 | Jun 2, 2021 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 246,146 | — | — | 246,146 | Aug 11, 2020 |
| Bashan Dror | President and CEO | Award / Grant | 447,927 | — | — | 447,927 | Aug 11, 2020 |
| Rubin Eyal | Sr. VP and CFO | Award / Grant | 246,146 | — | — | 246,146 | Aug 11, 2020 |
| Bashan Dror | President and CEO | Award / Grant | 447,927 | — | — | 447,927 | Aug 11, 2020 |
| Schwartz Aharon | — | Purchase | 64,000 | $2.43 | $155,520 | 64,000 | Apr 7, 2020 |
| Manor Moshe | President & CEO | Purchase | 50,000 | $0.81 | $40,500 | 50,000 | May 16, 2017 |
| Camber Capital Management LLC | — | Sale | 2,500,000 | $0.32 | $800,000 | 10,775,000 | Dec 2, 2016 |
| Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | 122,162 | — | — | 585,916 | Sep 15, 2016 |
| Maimon Yossi | Vice President & CFO | Purchase | 10,000 | $0.78 | $7,800 | 10,000 | Dec 14, 2015 |
| Camber Capital Management LLC | — | Purchase | 423 | $1.03 | $436 | 13,275,000 | Oct 19, 2015 |
| Bronfeld Zeev | — | Other | 324,372 | — | — | 2,162,481 | Oct 2, 2014 |
| Bronfeld Zeev | — | Other | 1,838,109 | — | — | 1,838,109 | Sep 16, 2014 |
| Bio-Cell Ltd | — | Other | 8,556,371 | — | — | 1,509,948 | Sep 16, 2014 |
| Bronfeld Zeev | — | Sale | 4,400,000 | $2.47 | $10,868,000 | 10,066,319 | Aug 13, 2014 |
| Bio-Cell Ltd | — | Sale | 4,400,000 | $2.47 | $10,868,000 | 10,066,319 | Aug 13, 2014 |
| Akirov Alfred | — | Sale | 5,000 | $5.08 | $25,400 | 4,917,713 | Aug 14, 2013 |
| Akirov Alfred | — | Sale | 10,000 | $5.70 | $57,000 | 5,027,713 | Mar 12, 2013 |
| Akirov Alfred | — | Sale | 1,898 | $5.95 | $11,293 | 5,056,013 | Mar 8, 2013 |
| Akirov Alfred | — | Sale | 700 | $5.71 | $3,997 | 5,081,346 | Mar 6, 2013 |
| Lauterbach Sandra Leigh | VP, Sales & Commercial Affairs | Award / Grant | 20,000 | — | — | 20,000 | Jul 16, 2012 |
| Palash Tzvi | Chief Operating Officer | Award / Grant | 102,000 | — | — | 102,000 | Jul 16, 2012 |
| Maimon Yossi | Vice President & CFO | Award / Grant | 185,000 | — | — | 185,000 | Jul 16, 2012 |
| Almon Einat Brill | SVP, Product Development | Award / Grant | 185,000 | — | — | 185,000 | Jul 16, 2012 |
| Shaaltiel Yoseph | Executive VP, R&D | Award / Grant | 210,000 | — | — | 210,000 | Jul 16, 2012 |
| Aviezer David | President & CEO | Award / Grant | 418,000 | — | — | 418,000 | Jul 16, 2012 |